<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Eighty eight patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> were studied to determine the clinical and pathological features and the prognosis </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the patients had <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0001875'>Neutropenia</z:hpo> was seen in 44% and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> in 78% patients </plain></SENT>
<SENT sid="3" pm="."><plain>The subtypes included <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> in six, <z:hpo ids='HP_0004828'>refractory anemia with ringed sideroblasts</z:hpo> in three, <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts in 30, <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts in transformation in 32 and <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001903'>anemia</z:hpo> in 17 patients </plain></SENT>
<SENT sid="4" pm="."><plain>Forty four patients who received chemotherapy were evaluable for response </plain></SENT>
<SENT sid="5" pm="."><plain>Three of the 15 patients treated with <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi> achieved partial remission </plain></SENT>
<SENT sid="6" pm="."><plain>Eighteen patients were treated with low dose <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> and complete remission was achieved in five and partial response in six patients </plain></SENT>
<SENT sid="7" pm="."><plain>Aggressive chemotherapy was given to 11 patients at the <z:hpo ids='HP_0003674'>onset</z:hpo> of the illness resulting in complete remission in six and partial response in two patients </plain></SENT>
<SENT sid="8" pm="."><plain>Nineteen of the 88 patients transformed to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The crude survival of <z:hpo ids='HP_0000001'>all</z:hpo> the patients ranged from 15 days to 22.5 months </plain></SENT>
<SENT sid="10" pm="."><plain>The mortality was due to <z:mp ids='MP_0001914'>hemorrhage</z:mp> in 15% and <z:mpath ids='MPATH_681'>septicemia</z:mpath> in 85% </plain></SENT>
<SENT sid="11" pm="."><plain>Our data reveals ineffectiveness of the current therapy and emphasizes on the need to develop newer therapeutic approaches </plain></SENT>
</text></document>